Drug Profile
PYN 16
Latest Information Update: 28 Aug 2021
Price :
$50
*
At a glance
- Originator ElexoPharm GmbH; Phynova
- Class Antibacterials; Herbal medicines; Skin disorder therapies
- Mechanism of Action Steroid inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Wounds
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for research development in Wounds in Germany (Topical)
- 28 Aug 2021 No recent reports of development identified for research development in Wounds in United Kingdom (Topical)
- 18 Jul 2017 Early research in Wounds in Germany (Topical) (Phynova pipeline, July 2017)